IDBS Release: Siena Biotech S.p.A. To Implement ActivityBase For Lead Discovery Data Management
10/19/2005 5:09:39 PM
IDBS, provider of integrated data management, analysis and decision-making software for biopharmaceutical discovery research, announced today that Sienabiotech S.p.A. of Italy will implement IDBS’ ActivityBase suite. Sienabiotech is a research-based drug discovery company with particular expertise in CNS disorders, operating across the spectrum of discovery activities from target identification to phase IIa clinical trials. Sienabiotech will deploy ActivityBase in Lead Discovery to capture, manage and integrate biological, chemical and inventory data.
comments powered by